anmelden
QIAGEN Aktie
37,02
EUR
-0,47
EUR
-1,25
%
42,98
USD
-0,26
USD
-0,60
%
QIAGEN jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
QIAGEN Aktie Analyse
| 06.05.11 | QIAGEN add | WestLB AG | |
| 02.05.11 | QIAGEN sell | Goldman Sachs Group Inc. | |
| 02.05.11 | QIAGEN overweight | Barclays Capital | |
| 29.04.11 | QIAGEN kaufen | Hamburger Sparkasse AG (Haspa) | |
| 29.04.11 | QIAGEN kaufen | Independent Research GmbH | |
| 28.04.11 | QIAGEN overweight | Piper Jaffray & Co. | |
| 21.04.11 | QIAGEN buy | WestLB AG | |
| 13.04.11 | QIAGEN neutral | HSBC | |
|
Werbung
|
|||
| 06.04.11 | QIAGEN overweight | Barclays Capital | |
| 05.04.11 | QIAGEN kaufen | Independent Research GmbH | |
| 05.04.11 | QIAGEN kaufen | Hamburger Sparkasse AG (Haspa) | |
| 04.04.11 | QIAGEN hold | Vontobel Research | |
| 23.02.11 | QIAGEN sell | Goldman Sachs Group Inc. | |
| 10.02.11 | QIAGEN buy | Société Générale Group S.A. (SG) | |
| 03.02.11 | QIAGEN buy | Société Générale Group S.A. (SG) | |
| 03.02.11 | QIAGEN kaufen | Hamburger Sparkasse AG (Haspa) | |
| 02.02.11 | QIAGEN overweight | Barclays Capital | |
| 02.02.11 | QIAGEN hold | Vontobel Research | |
| 02.02.11 | QIAGEN overweight | Piper Jaffray & Co. | |
| 02.02.11 | QIAGEN buy | WestLB AG | |
| 01.02.11 | QIAGEN buy | Deutsche Bank AG | |
| 01.02.11 | QIAGEN hold | Vontobel Research | |
| 01.02.11 | QIAGEN neutral | UBS AG | |
| 01.02.11 | QIAGEN kaufen | Independent Research GmbH | |
| 28.01.11 | QIAGEN hold | Société Générale Group S.A. (SG) | |
| 26.01.11 | QIAGEN neutral | UBS AG | |
| 19.01.11 | QIAGEN neutral | Exane-BNP Paribas SA | |
| 14.01.11 | QIAGEN kaufen | Der Aktionärsbrief | |
| 11.01.11 | QIAGEN kaufen | Hamburger Sparkasse AG (Haspa) | |
| 10.01.11 | QIAGEN kaufen | Independent Research GmbH | |
| 20.12.10 | QIAGEN kaufen | Hamburger Sparkasse AG (Haspa) | |
| 13.12.10 | QIAGEN overweight | Barclays Capital | |
| 15.11.10 | QIAGEN sector perform | RBC Capital Markets | |
| 12.11.10 | QIAGEN overweight | Piper Jaffray & Co. | |
| 11.11.10 | QIAGEN overweight | Barclays Capital | |
| 11.11.10 | QIAGEN hold | Vontobel Research | |
| 10.11.10 | QIAGEN hold | Société Générale Group S.A. (SG) | |
| 09.11.10 | QIAGEN hold | Vontobel Research | |
| 09.11.10 | QIAGEN buy | Commerzbank Corp. & Markets | |
| 09.11.10 | QIAGEN kaufen | Independent Research GmbH | |
| 08.11.10 | QIAGEN neutral | UBS AG | |
| 13.10.10 | QIAGEN hold | Vontobel Research | |
| 06.10.10 | QIAGEN kaufen | Hamburger Sparkasse AG (Haspa) | |
| 21.09.10 | QIAGEN kaufen | Independent Research GmbH | |
| 14.09.10 | QIAGEN halten | Hamburger Sparkasse AG (Haspa) | |
| 12.08.10 | QIAGEN neutral | UBS AG | |
| 12.08.10 | QIAGEN overweight | Barclays Capital | |
| 11.08.10 | QIAGEN hold | Vontobel Research | |
| 11.08.10 | QIAGEN outperform | Exane-BNP Paribas SA | |
| 10.08.10 | QIAGEN buy | WestLB AG | |
Werbung
Werbung
